Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance

por Peraman, Ramalingam, Sure, Sathish Kumar, Dusthackeer, V. N. Azger, Chilamakuru, Naresh Babu, Yiragamreddy, Padmanabha Reddy, Pokuri, Chiranjeevi, Kutagulla, Vinay Kumar, Chinni, Santhivardhan
Publicado 2021

Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c

por Nirmal, Christy Rosaline, Rajadas, Sam Ebenezer, Balasubramanian, Mahizhaveni, Magdaline, Divya, Chilamakuru, Naresh Babu, Dinesh, Rajkumar, Radhakrishnan, A., Paraman, Ramalingam, Mondal, Rajesh, Dusthackeer, V. N. Azger
Publicado 2023

Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofazimine

por Saravanan, Pasupathy, Dusthackeer, V. N. Azger, Rajmani, R. S., Mahizhaveni, B., Nirmal, Christy R., Rajadas, Sam Ebenezer, Bhardwaj, Neerupma, Ponnuraja, C., Bhaskar, Adhin, Hemanthkumar, A. K., Ramachandran, Geetha, Tripathy, Srikanth P.
Publicado 2021

In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor

por Mondal, Rajesh, Dusthackeer V. N., Azger, Kannan, Palaniyandi, Singh, Amit Kumar, Thiruvengadam, Kannan, Manikkam, Radhakrishnan, A. S., Shainaba, Balasubramanian, Mahizhaveni, Elango, Padmasini, Ebenezer Rajadas, Sam, Bharadwaj, Dinesh, Arumugam, Gandarvakottai Senthilkumar, Ganesan, Suresh, Kumar A. K., Hemanth, Singh, Manjula, Patil, Shripad, U. C. A., Jaleel, Doble, Mukesh, R., Balagurunathan, Tripathy, Srikanth Prasad, Kumar, Vanaja
Publicado 2023